President Donald Trump signed an executive order that could make it easier for scientists to study cannabis for medical use.

The FDA is weighing a change that could make warning labels on dietary supplements appear less often on packaging.

The FDA approved Lerochol, a monthly PCSK9 inhibitor, for adults with hypercholesterolemia to reduce LDL-C levels alongside diet and exercise.

FDA approves Rybrevant Faspro, a subcutaneous amivantamab formulation, for all indications previously held by the intravenous formulation.

Traditional Chinese medicine (TCM) pediatric tuina may be safe and effective as supplementary therapy in children with severe pneumonia.

The HHS has ended several health grants to one of the nation’s largest pediatricians’ groups, a move the organization says could hurt children and families.

Long-term exposure to polluted air can weaken the health benefits of regular exercise, according to a recent review.

President Donald Trump has signed an executive order declaring the street drug fentanyl a weapon of mass destruction.

Influenza season is getting an early start in New York City, with doctors reporting a sharp jump in cases weeks sooner than normal.

A peanut patch immunotherapy demonstrated efficacy and safety in desensitizing young children with peanut allergy in a phase 3 study.

Early termination of the 6-minute walk test may be a practical and prognostic marker for severe adverse events in patients with COPD.

Topline data from the phase 3 ATTAIN-MAINTAIN trial evaluated orforglipron for weight maintenance after initial treatment with Wegovy or Zepbound in adults with obesity or overweight.